bmi required for glp 1 requirements A Balancing Act: GLP-1 Receptor Agonists Non-Diabetic Obesity – Clinical Correlations Medicare GLP-1 Drug Coverage GLP-1 Eligibility Explained: BMI Cutoffs

Patients typically start with a lower dose of Wegovy, which is gradually increased over 16-20 weeks to minimize potential side effects such as nausea, vomiting, and diarrhea

I think this is just another validation that its not their fault, that obesity has biological underpinnings.

In contrast, if weight optimization is the primary objective before conception, short-term therapy followed by an appropriate washout period may be reasonable

Human Data: So far, large-scale studies in humans have not shown a clear, significant link between GLP-1 use and an increase in medullary thyroid cancer

van Bloemendaal L, Veltman DJ, ten Kulve JS, Drent ML, Barkhof F, Diamant M, et al

Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions